Sector ratings Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
00:00:00 03/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.760 USD | +1.47% |
|
+9.52% | +0.36% |
| 09-21 | Perspective Therapeutics, Inc.(NYSEAM:CATX) dropped from S&P Biotechnology Select Industry Index | CI |
| 09-18 | William Blair Initiates Perspective Therapeutics With Outperform Rating | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 315M | - | BBB | - | - | ||||
| 74.16B | AAA | |||||||
| 57.39B | A | |||||||
| 47.64B | AAA | |||||||
| 44.29B | - | B | - | - | ||||
| 42.5B | AAA | |||||||
| 40.71B | - | |||||||
| 30.97B | A | |||||||
| 28.53B | AAA | |||||||
| 24.34B | - | - | - | - | ||||
| 24.27B | - | BBB | - | - | ||||
| 20.32B | A | |||||||
| 16.73B | BBB | |||||||
| 15.16B | AA | |||||||
| 14.96B | - | - | - | - | ||||
| 14.63B | AA | |||||||
| 14.47B | BB | |||||||
| 14.38B | AA | |||||||
| 13.85B | AA | |||||||
| 13.83B | A | - | ||||||
| Average | 27.67B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
